Recently, we reported that parkin KO inhibits neuronal development via regulation of proteasomal degradation of p21 [29].We, thus, hypothesized that mutations in parkin would inhibit the degradation of p21, leading to cell cycle arrest, which ultimately results in tumor growth inhibition. Here, CDKN1A is linked to neoplasm.